|
|
Bibliography
- Acton RT, Barton JC, Casebeer L, Talley L. Survey of physician
knowledge about hemochromatosis.
Genet Med 2002; 4(3):136–41.
View abstract on PubMed
- Adamc PC, Brissot P, Powell LW. EASL International Conference on
Haemochromatosis. J Hepatol 2000; 33(3):485–504.
View abstract on PubMed
- Adams PC, Walker AP, Acton RT. A primer for predicting risk
of disease in HFE linked hemochromatosis. Genet Test 2001;
5(4):311–316.
View abstract on PubMed
- Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelonning K,
Fjosne U et al. Screening for hemochromatosis: high prevalence and
low morbidity in an unselected population of 65,238 persons. Scand J
Gastroenterol 2001; 36(10):1108–15.
View abstract on PubMed
- Barton JC, Acton RT. Inheritance of two HFE mutations in African
Americans: cases with hemochromatosis phenotypes and estimates of
hemochromatosis phenotype frequency. Genet Med. 2001; 3(4):294–300.
View abstract on PubMed
- Barton JC and Edwards CQ. Hemochromatosis: Genetics, pathophysiology,
diagnosis, and treatment. United Kingdom: Cambridge University Press,
2000.
- Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ
et al. Management of hemochromatosis. Hemochromatosis Management Working
Group. Ann Intern Med 1998; 129(11):932–939.
View abstract on PubMed
- Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification
of the S65C mutation in Alabama hemochromatosis probands. Blood Cells
Mol Dis 1999; 25(3-4):147–155.
View abstract on PubMed
- Beutler E, Felitti V, Koziol J, Ho N, Gelbart T. Penetrance of the
845G - A(C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211–218.
View abstract on PubMed
- Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Charon D, Dupont B et al.
Nomenclature for factors of the HLA system. Tissue Antigens 1997;
49(3)PartII:297–321.
View abstract on PubMed
- Bomford A. Genetics of haemochromatosis. Lancet 2002;
360(9346): 1673–81.
View abstract on PubMed
- Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: A unifying analysis of published intervention trials.
J Med Screen 1996; 3(4):178–184.
View abstract on PubMed
- Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: Expectations based on a study of relatives of
symptomatic probands. J Med Screen 1996; 3(4):171–177.
View abstract on PubMed
- Braunwald E, Fauci A, Kasper D, Hauser S, et al. Harrison's. 15th
ed. 2001.
- Britton RS, Fleming RE, Parkkila S, Waheed A, Sly WS, Bacon BR.
Pathogenesis of hereditary hemochromatosis: Genetics and beyond. Semin
Gastrointest Dis 2002; 13(2):68–79.
View abstract on PubMed
- Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM
et al. Disease-related conditions in relatives of patients with
hemochromatosis. N Engl J Med 2000; 343(21):1529–35.
View abstract on PubMed
- Burke W, Emery J. Genetics education for primary-care providers.
Nat Rev Genet 2002; 3:561.
View abstract on PubMed
- Burke W, Phatak P, Weinberg ED, Bonkovsky H. The Iron Disorders
Institute Guide to Hemochromatosis. Nashville, TN: Cumberland House,
2001.
- Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC et
al. Hereditary hemochromatosis: Gene discovery and its implications for
population-based screening. JAMA 1998; 280(2):172–178.
View abstract on PubMed
- Cadet E, Capron D, Perez A, Crepin S, Arlot S., Ducroix J et al. A
targeted approach significantly increases the identification rate of
patients with undiagnosed haemochromatosis. J Intern Med
2003; 253:217–224.
View abstract on PubMed
- Cartwright GE, Skolnick M, Amos DB, Edwards CQ, Kravitz K, Johnson
A. Inheritance of hemochromatosis: Linkage to HLA. Trans Assoc Am
Physicians 1978; 91:273–281.
View abstract on PubMed
- Centers for Disease Control and Prevention. Recommendations to
Prevent and Control Iron Deficiency in the United States. MMWR 1998; 47
(No. RR-3)
http://www.cdc.gov/mmwr/preview/mmwrhtml/00051880.htm
- Cogswell ME, Burke W, McDonnell SM, Franks AL. Screening for hemochromatosis: A public health perspective. Am J Prev Med 1999;
16(2):134–140.
View abstract on PubMed
- Dadone MM, Kushner JP, Edwards CQ, Bishop DT, Skolnick MH.
Hereditary hemochromatosis: Analysis of laboratory expression of the
disease by genotype in 18 pedigrees. Am J Clin Pathol 1982;
78(2):196–207.
View abstract on PubMed
- Dolbey CH. Hemochromatosis: A review. Clin J Oncol Nurs 2001; 5(6):257–260.
View abstract on PubMed
- EASL International Consensus Conference on Haemochromatosis. J
Hepatol 2000; 33:485–504.
View abstract on PubMed
- Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N et al.
The hemochromatosis gene product complexes with the transferrin receptor
and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A
1998; 95(4):1472–1477.
View abstract on PubMed
- Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E et
al. The hemochromatosis founder mutation in HLA-H disrupts
beta2-microglobulin interaction and cell surface expression. J Biol Chem
1997; 272(22):14025–14028.
View abstract on PubMed
- Fleming DJ, Tucker KL, Jacques PF, Dallal GE, Wilson PW, Wood RJ.
Dietary factors associated with the risk of high iron stores in the
elderly Framingham Heart Study cohort. Am J Clin Nutr.
2002;76(6):1375–84.
View Abstract on PubMed
- Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu Rev Physiol 2002; 64:663–680.
View abstract on PubMed
- Franks AL, Burke W. Will the real hemochromatosis please stand
up? Ann Intern Med 1999;130(12):1018–9.
- Garry PJ, Hunt WC, Baumgartner RN. Effects of iron intake on iron
stores in elderly men and women: longitudinal and cross-sectional
results. J Am Coll Nutr. 2000;19(2):262-9.
View Abstract on PubMed
- Haddow JE, Palomaki GE, McClain M, Craig W. Hereditary
haemochromatosis and hepatocellular carcinoma in males: a strategy for
estimating the potential for primary prevention. J Med Screen.
2003;10(1):11–3.
View abstract on PubMed
- Hanson EH, Imperatore G, Burke W. HFE Gene and Hereditary
Hemochromatosis: A HuGE Review. Am J Epidemiol 2001;
154(3):193–206.
View abstract on PubMed
- Imperatore GM, Pinsky LEM, Motulsky AM, Reyes MP, Bradley LAP, Burke
WM. Hereditary hemochromatosis: Perspectives of public health, medical
genetics, and primary care. Genet Med 2003; 5(1):1–8.
View abstract on PubMed
- Lang LH. Iron overload gene tied to colon cancer increased risk.
Carolina 2003 Jan 15.
- Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA et
al. Crystal structure of the hemochromatosis protein HFE and
characterization of its interaction with transferrin receptor. Cell
1998; 93(1):111–123.
View abstract on PubMed
- Looker AC, Johnson CL. Prevalence of elevated serum transferrin
saturation in adults in the United States. Ann Intern Med 1998;
129(11):940–945.
View abstract on PubMed
- Mainous AG, III, Gill JM, Pearson WS. Should we screen for hemochromatosis? An examination of evidence of downstream effects on
morbidity and mortality. Arch Intern Med 2002; 162(15):1769–1774.
View abstract on PubMed
- McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC
et al. A survey of 2,851 patients with hemochromatosis: Symptoms and
response to treatment. Am J Med 1999; 106(6):619–624.
View abstract on PubMed
- McNamara L, MacPhail AP, Gordeuk VR, Hasstedt SJ, Rouault T. Is
there a link between African iron overload and the described mutations
of the hereditary haemochromatosis gene? Br J Haematol 1998;
102(5):1176–1178.
View abstract on PubMed
- Merck Manual of Diagnosis and Therapy. 17th ed. Whitehouse Station:
Merck Research Laboratories, 1999.
- Morrison ED, Brandhagen DJ, Phatak PD, Barton JC, Krawitt EL, El-Serag
HB, Gordon SC, Galan MV, Tung BY, Ioannou GN, Kowdley KV. Serum ferritin
level predicts advanced hepatic fibrosis among U.S. patients with
phenotypic hemochromatosis. Ann Intern Med 2003;138(8):627–33.
View abstract on PubMed
- Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711
hemochromatosis probands: evidence for S65C implication in mild form of
hemochromatosis. Blood 1999; 93(8):2502–5.
View abstract on PubMed
- Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ,
Strohmeyer G. Survival and causes of death in cirrhotic and in
noncirrhotic patients with primary hemochromatosis. N Engl J Med.
1985; 313(20):1256–62.
View Abstract on PubMed
- Nowlan W. A Rational View of Insurance and Genetic Discrimination.
Science 2002; 297:195.
View abstract on PubMed
- Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW.
A population-based study of the clinical expression of the
hemochromatosis gene. N Engl J Med 1999; 341(10):718–24.
View abstract on PubMed
- Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman
RC et al. Immunohistochemistry of HLA-H, the protein defective in
patients with hereditary hemochromatosis, reveals unique pattern of
expression in gastrointestinal tract. Proc Natl Acad Sci U S A 1997;
94(6):2534–2539.
View abstract on PubMed
- Philpott CC. Molecular aspects of iron absorption: Insights into the
role of HFE in hemochromatosis. Hepatology 2002; 35(5):993–1001.
View abstract on PubMed
- Physicians' Desk Reference. 29th ed. Oradell, NJ: Medical Economics
Co., 2002–2003.
- Pietrangelo A, Montosi G, Totaro A, Garuti C, Conte D, Cassanelli S
et al. Hereditary hemochromatosis in adults without pathogenic mutations
in the hemochromatosis gene. N Engl J Med 1999; 341(10):725–732.
View abstract on PubMed
- Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon
mutations and polymorphisms in the hemochromatosis gene. Genet Test
2000; 4(2):151–161.
View abstract on PubMed
- Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med 1998; 129(11):925–931.
View abstract on PubMed
- Reyes M, Dunet D, Blanck HM, Grossniklaus D. Hemochromatosis:
information and resources for health care providers. Centers for Disease
Control and Prevention Genomics and Population Health: United States,
2003. Atlanta, GA; 2004
- Rhodes DA, Trowsdale J. Alternate splice variants of the hemochromatosis gene HFE. Immunogenetics 1999; 49(4):357–359.
View abstract on PubMed
- Shaywitz DA. Treating symptoms and missing disease. New York
Times 2003; 7.
- Simon M, Bourel M, Fauchet R, Genetet B. HLA and "non-immunological"
disease: Idiopathic haemochromatosis. Lancet 1976; 2(7992):973–974.
View abstract on PubMed
- Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM,
Bowman BA et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;
285(17):2216–2222.
View abstract on PubMed
- Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary
haemochromatosis, anaemia of chronic disease, and secondary iron
overload. Lancet 2002; 359(9308):786–790.
View abstract on PubMed
- Umek RM, Lin SW, Vielmetter J, Terbrueggen RH, Irvine B, Yu CJ,
Kayyem JF, Yowanta H, Blackburn GF, Farkas DH, Chen YP. Electronic
detection of nucleic acids: a versatile platform for molecular
diagnostics. J Mol Diagn 2001; 3(2):74–84.
View abstract on PubMed
- Waheed A, Parkkila S, Saarnio J, Fleming RE, Zhou XY, Tomatsu S et
al. Association of HFE protein with transferrin receptor in crypt
enterocytes of human duodenum. Proc Natl Acad Sci U S A 1999;
96(4):1579–1584.
View abstract on PubMed
- Waheed A, Parkkila S, Zhou XY, Tomatsu S, Tsuchihashi Z, Feder JN,
Schatzman RC, Britton RS, Bacon BR, Sly WS. Hereditary
hemochromatosis: effects of C282Y and H63D mutations on association with
beta2-microlobulin, intracellular porcessing, and cell surface
expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S
A. 1997; 94(23):12384–9.
View abstract on PubMed
- Wallace DF, Walker AP, Pietrangelo A, Clare M, Bomford AB, Dixon JL,
Powell, LW, Subramaniam VN, Dooley JS. Frequency of the S65C mutation
of HFE and iron overload in 309 subjects heterozygous for C282Y. J
Hepatol 2002; 36(4):474–9.
View abstract on PubMed
- Whittington CA, Kowdley KV. Review article: haemochromatosis.
Alimentary Pharmacology & Therapeutics 2002; 16(12):1963–1975.
View abstract on PubMed
- Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper
LM, Jennings BA. Incidence of liver disease in people with HFE
mutations. Gut. 2000;46(3):401–4.
View Abstract on PubMed
- Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice
guideline development task force of the College of American
Pathologists: Hereditary hemochromatosis. Clin Chim Acta 1996;
245(2):139–200.
View abstract on PubMed
- Wright SM, Finical J. Beyond leeches. Therapeutic phlebotomy
today. Am J Nurs 2000; 100(7):55–9, 61, 63.
View abstract on PubMed
- Zaahl MG, Merryweather-Clarke AT, Cotze MJ, Vandermerwe S, Warnich
L, Robson KJ, Analysis Of Genes Implicated In Iron Regulation In
Individuals Presenting With Primary Iron Overload. Hum Genet 2004
Oct; 115(5):409–7.
- Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J et al.
HFE gene knockout produces mouse model of hereditary hemochromatosis.
Proc Natl Acad Sci U S A 1998; 95(5):2492–2497.
View abstract on PubMed
|
|